Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
38.28
+1.48 (4.02%)
At close: Jul 6, 2026, 4:00 PM EDT
38.06
-0.22 (-0.57%)
After-hours: Jul 6, 2026, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $28.35. The average 1-year stock price forecast is 25.94% lower than the current stock price, while the lowest is $21 (-45.14%) and the highest is $40 (+4.49%).
Price Target: $28.35 (-25.94%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 3 | 3 | 2 | 2 |
| Hold | 10 | 12 | 12 | 12 | 11 | 11 |
| Sell | 1 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Reiterates $36 | Hold | Reiterates | $36 | -5.96% | Jul 1, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $32 → $40 | Buy | Maintains | $32 → $40 | +4.49% | Jul 1, 2026 |
| Barclays | Barclays | Buy Maintains $29 → $39 | Buy | Maintains | $29 → $39 | +1.88% | Jun 18, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 9, 2026 |
| Jefferies | Jefferies | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | -36.00% | May 12, 2026 |
Financial Forecast
Revenue This Year
3.15B
from 2.35B
Increased by 34.26%
Revenue Next Year
4.46B
from 3.15B
Increased by 41.56%
EPS This Year
0.36
from 1.10
Decreased by -67.32%
EPS Next Year
0.89
from 0.36
Increased by 147.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2B | ||
| Avg | 3.2B | ||
| Low | 3.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.3% | ||
| Avg | 34.3% | ||
| Low | 34.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.36 | ||
| Avg | 0.36 | ||
| Low | 0.36 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -67.3% | ||
| Avg | -67.3% | ||
| Low | -67.3% |